Results 41 to 50 of about 24,947,267 (297)

Anti-SARS-CoV-2 S-RBD IgG antibody and anti-SARS-CoV-2 NAb levels.

open access: yes, 2023
Anti-SARS-CoV-2 S-RBD IgG antibody and anti-SARS-CoV-2 NAb levels.
Lugyanti Sukrisman (4808703)   +11 more
core   +1 more source

Maternal SARS‐CoV‐2 infection: The potential vertical transmission of SARS‐CoV‐2 and impact on neonates: A review

open access: yesPediatric Discovery, 2023
Severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2), a large, lipid‐enveloped, single‐stranded RNA virus, is a highly contagious virus that caused coronavirus disease 2019 (COVID‐19), declared a pandemic by the World Health Organization on March
Wei Xia, Zhoujie Peng
doaj   +1 more source

Therapeutic antibodies under development for SARS‐CoV‐2

open access: yesView, 2022
The world is experiencing one of the most difficult moments in history with COVID‐19, which has rapidly developed into a worldwide pandemic with a significant health and economic burden.
Zetong Ma   +7 more
doaj   +1 more source

Hyperimmunized Chickens Produce Neutralizing Antibodies against SARS-CoV-2 [PDF]

open access: yes, 2022
The novel severe acute respiratory syndrome (SARS) coronavirus, SARS-CoV-2, is responsible for the global COVID-19 pandemic. Effective interventions are urgently needed to mitigate the effects of COVID-19 and likely require multiple strategies.
Rodrigo A. Gallardo   +12 more
core   +1 more source

Guillain‐Barré syndrome after SARS‐CoV‐2 infection

open access: yesJournal of General and Family Medicine, 2022
We herein report a case of Guillain‐Barré syndrome (GBS) after SARS‐CoV‐2 infection. The patient was a close contact with a SARS‐CoV‐2 patient. Initially, she did not have any symptoms and quarantined at a hotel.
Mikiya Kajita   +5 more
doaj   +1 more source

Erythema Multiforme Major following SARS‐CoV‐2 vaccine

open access: yesClinical Case Reports, 2021
Erythema multiforme major, an immune‐mediated skin reaction to infections or medications with oral involvement, should be taken into account as a potential side effect of several vaccines, including SARS‐CoV‐2.
Alberto Maria Saibene   +7 more
doaj   +1 more source

SARS‐CoV‐2 infection with bilateral intralabyrinthine hemorrhage

open access: yesClinical Case Reports, 2022
A 47‐year‐old woman presented with the complaint of sudden hearing loss associated with vertigo. Serological testing was positive for IgM and negative for IgG COVID‐19 antibodies, with no other associated factors.
Vagner Antonio Rodrigues daSilva   +6 more
doaj   +1 more source

Оценка Т-клеточного иммунитета к SARS-CoV-2 у переболевших и вакцинированных против COVID-19 лиц с помощью ELISPOT набора ТиграТест® SARS-CoV-2 [PDF]

open access: yes, 2021
With the onset of the COVID-19 pandemic, a number of molecular-based tests have been developed to diagnose SARS-CoV-2 infection. However, numerous available serological tests lack sufficient sensitivity or specificity.
Р. А. Хамитов   +11 more
core   +1 more source

SARS CoV- 2 vaccination induces antibodies against cardiolipin

open access: yesBMC Research Notes, 2022
Objective Cases of thrombosis have been reported after administration of SARS-CoV-2 vaccines, with controversial results relating to Oxford-AstraZeneca’s ChAdOx1-S.
George Krashias   +5 more
doaj   +1 more source

SARS-COV-2.pptx

open access: yes, 2020
Presentation given at Melbourne Integrative Genomics on 4/3/2020Abstract:Analysis of Sars-COV-2 direct RNA sequence dataAbstract SARS-Cov-2 (virus leading to COVID-19) transferred from an unknown animal host into humans in November 2019, and has since ...
Lachlan Coin (8249877)
core   +1 more source

Home - About - Disclaimer - Privacy